Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 8, 2011, Pages 1695-1702

  Jia, Guanghong ^a   Aggarwal, Anshu ^a   Yohannes, Amanuel ^a   Gangahar, Deepak M ^b   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Nebraska Heart Hospital   (United States)

Author keywords

Angiotensin II; Connexins; Intimal hyperplasia; Restenosis; Vascular smooth muscle cells; Vein graft disease

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CONNEXIN 43; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR AP 2;

AGED; ARTICLE; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; PHOSPHORYLATION; RNA INTERFERENCE; SAPHENOUS VEIN; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TIME; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

AGED; ANGIOTENSIN II; BLOTTING, WESTERN; CELLS, CULTURED; CONNEXIN 43; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; RECEPTOR CROSS-TALK; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, IGF TYPE 1; RNA INTERFERENCE; SAPHENOUS VEIN; TIME FACTORS; TRANSCRIPTION FACTOR AP-2; UP-REGULATION;

EID: 79960329471     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01161.x     Document Type: Article

References (35)

1. Anstadt MP, Franga DL, Portik-Dobos V, et al. Native matrix metalloproteinase characteristics may influence early stenosis of venousversusarterial coronary artery bypass grafting conduits. Chest. 2004; 125: 1853-8.
2. Huang B, Dreyer T, Heidt M, et al. Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery. Eur J Cardiothorac Surg. 2002; 21: 1002-8.
3. Dhume AS, Agrawal DK. Inability of vascular smooth muscle cells to proceed beyond S phase of cell cycle, and increased apoptosis in symptomatic carotid artery disease. J Vasc Surg. 2003; 38: 155-61.
4. Kwak BR, Mulhaupt F, Veillard N, et al. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2002; 22: 225-30.
5. Sukhanov S, Higashi Y, Shai SY, et al. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2007; 27: 2684-90.
6. Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res. 2000; 86: 125-30.
7. Ruiz-Torres A, Lozano R, Melón J, et al. L-calcium channel blockade induced by diltiazem inhibits proliferation, migration and F-actin membrane rearrangements in human vascular smooth muscle cells stimulated with insulin and IGF-1. Int J Clin Pharmacol Ther. 2003; 41: 386-91.
8. Schmidt-Ott KM, Kagiyama S, Phillips MI. The multiple actions of angiotensin II in atherosclerosis. Regul Pept. 2000; 93: 65-77.
9. Dimmeler S, Zeiher AM. Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors. Regul Pept. 2000; 90: 19-25.
10. Wong CW, Burger F, Pelli G, et al. Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice. Cell Commun Adhes. 2003; 10: 395-400.
11. Jia G, Mitra AK, Cheng G, et al. Angiotensin II and IGF-1 regulate connexin43 expressionviaERK and p38 signaling pathways in vascular smooth muscle cells of coronary artery bypass conduits. J Surg Res. 2007; 142: 137-42.
12. Jia G, Cheng G, Agrawal DK. Differential effects of insulin-like growth factor-1 and atheroma-associated cytokines on cell proliferation and apoptosis in plaque smooth muscle cells of symptomatic and asymptomatic patients with carotid stenosis. Immunol Cell Biol. 2006; 84: 422-9.
13. Jia G, Cheng G, Gangahar DM, et al. Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cellsviathe MAPK-AP-1 signaling pathway. J Mol Cell Cardiol. 2008; 44: 882-90.
14. Gentile AT, Mills JL, Westerband A, et al. Characterization of cellular density and determination of neointimal extracellular matrix constituents in human lower extremity vein graft stenoses. Cardiovasc Surg. 1999; 7: 464-9.
15. Dethlefsen SM, Shepro D, D'Amore PA. Comparison of the effects of mechanical stimulation on venous and arterial smooth muscle cellsin vitro. J Vasc Res. 1996; 33: 405-13.
16. Wei CY, Chou YH, Ho FM, et al. Signaling pathways of LIGHT induced macrophage migration and vascular smooth muscle cell proliferation. J Cell Physiol. 2006; 209: 735-43.
17. Grant MB, Wargovich TJ, Ellis EA, et al. Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens. Regul Pept. 1996; 67: 137-44.
18. Allen RT, Krueger KD, Dhume A, et al. Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells. Apoptosis. 2005; 10: 525-35.
19. Ma Y, Zhang L, Peng T, et al. Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB. Endocrinology. 2006; 147: 1256-63.
20. Müller C, Reddert A, Wassmann S, et al. Insulin-like growth factor induces up-regulation of AT(1)-receptor gene expression in vascular smooth muscle cells. J Renin Angiotensin Aldosterone Syst. 2000; 1: 273-7.
21. Daemen MJ, Lombardi DM, Bosman FT, et al. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991; 68: 450-6.
22. Yamamoto K, Ohishi M, Ho C, et al. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation. Hypertension. 2009; 54: 1353-9.
23. Nichenig G and Murphy TJ. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gen expression. Mol Pharm. 1994; 46: 653-9.
24. Rakesh K, Agrawal DK. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells. Int Immunopharmacol. 2005; 5: 1487-506.
25. Scheidegger KJ, Du J, Delafontaine P. Distinct and common pathways in the regulation of insulin-like growth factor-1 receptor gene expression by angiotensin II and basic fibroblast growth factor. J Biol Chem. 1999; 274: 3522-30.
26. Du J, Peng T, Scheidegger KJ, et al. Angiotensin II activation of insulin-like growth factor 1 receptor transcription is mediated by a tyrosine kinase-dependent redox-sensitive mechanism. Arterioscler Thromb Vasc Biol. 1999; 19: 2119-26.
27. Shi ZD, Ji XY, Berardi DE, et al. Interstitial flow induces MMP-1 expression and vascular SMC migration in collagen I gelsviaan ERK1/2-dependent and c-Jun-mediated mechanism. Am J Physiol Heart Circ Physiol. 2010; 298: H127-35.
28. Kumar N, Gilula NB. The gap junction communication channel. Cell. 1996; 84: 381-8.
29. López D, Rodríguez-Sinovas A, Agulló E, et al. Replacement of connexin 43 by connexin 32 in a knock-in mice model attenuates aortic endothelium-derived hyperpolarizing factor-mediated relaxation. Exp Physiol. 2009; 94: 1088-97.
30. Chanson M, Derouette JP, Roth I, et al. Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta. 2005; 1711: 197-207.
31. Teunissen BE, Jongsma HJ, Bierhuizen MF. Regulation of myocardial connexins during hypertrophic remodelling. Eur Heart J. 2004; 25: 1979-89.
32. Gerdes MJ, Myakishev M, Frost NA, et al. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res. 2006; 66: 7578-88.
33. Jeong MY, Kinugawa K, Vinson C, et al. AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene program. Circulation. 2005 111: 1645-51.
34. Fernandez-Cobo M, Stewart D, Drujan D, et al. Promoter activity of the rat connexin43 gene in NRK cells. J Cell Biochem. 2001; 81: 514-22.
35. Touyz RM, He G, Wu XH, et al. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension. 2001; 38: 6-64.